Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04699643
Status:
UNKNOWN
Last Update Posted:
2021-01-07
First Post:
2020-12-29
Brief Title:
FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors
Sponsor:
Organization:
EverNov Medicines Zhuhai Hengqin Co Ltd